Search Results 1141-1150 of 17673 for prednisone

  1. Lenalidomide (oral route) - Side effects & dosage - Mayo Clinic

    Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS). Patients with MDS may have very ...

  2. High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma - Mayo Clinic

    Endocrine therapy: No concurrent systemic corticosteroids including oral steroids (i.e., prednisone, dexamethasone), topical steroid creams or ointments, or any ...

  3. A Study of Sonidegib and Pembrolizumab in Advanced Solid Tumors - Mayo Clinic

    Requirement for systemic corticosteroids (> 10 mg daily prednisone equivalent) or other immunosuppressive medications ≤ 14 days prior to registration. Life ...

  4. Secnidazole (oral route) - Side effects & dosage - Mayo Clinic

    Secnidazole is used to treat vaginal infection (vaginosis) caused by bacteria in adult women and trichomoniasis (an infection of the sex organs in men or women ...

  5. Mayo Clinic

    Final days of 5X Challenge! 5X My Gift! The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology. 5X My Gift!

  6. Diseases and Conditions that Start with U - Mayo Clinic

    Ut · Uterine cancer. See. Endometrial cancer · Uterine fibroids · Uterine leiomyoma. See. Uterine fibroids · Uterine myoma. See. Uterine fibroids · Uterine polyps.

  7. A Study to Compare the Rate of Major Cardiovascular Implantable Electronic Device Infections with the Absorbable Antibacterial Envelope and without - Mayo Clinic

    ... Prednisone or equivalent; Hemodialysis or peritoneal dialysis; Prior Cardiac transplantation or existing Ventricular Assist Device (VAD); Require long-term ...

  8. Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS - Mayo Clinic

    Systemic chronic corticosteroid therapy (> 10 mg/day prednisone or equivalent) or any immunosuppressive therapy within 7 days of first dose of study treatment.

  9. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

    Corticosteroid therapy started at least 7 days prior to study entry (prednisone ≤ 10 mg daily or equivalent) is allowed as clinically warranted. Topical or ...

  10. Publications - Blanca C. Lizaola-Mayo, M.D.

    Jamal F, Elshaer A, Alatout MH, Odeh NB, Youssef A, Abo H, Elmasry S, Shahin T, Abdul H, Worden AR, Malik TA, Lizaola-Mayo BC. Second-line therapies in primary ...